Rafting in the Membrane. A Lesson Learnt from Lymphoproliferative Disorders

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E. et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 2000, s. 503-11.

2. Allsup, D.J., Kamiguti, A.S., Lin K. et al.: B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia. Cancer Res., 65, 2005, s. 7328-37.

3. Bechtel, D., Kurth, J., Unkel, C. et al.: Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood, 106, 2005, s. 4345-50.

4. Behrens, T.W., Jagadeesh, J., Scherle, P. et al.: Jaw1, a lymphoid-restricted membrane protein localized to the endoplasmic reticulum. J. Immunol., 153, 1994, s. 682-90.

5. Brauninger, A., Schmitz, R., Bechtel, D. et al.: Molecular biology of Hodgkin’s and Reed/Sternberg cells in Hodgkin’s lymphoma. Int. J. Cancer., 118, 2006, s. 1853-61.

6. Brdicka, T., Pavlistova, D., Leo, A. et al.: Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J. Exp. Med., 191, 2000, s. 1591-604.

7. Brdickova, N., Brdicka, T., Andera, L. et al.: Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. FEBS Lett., 507, 2001, s. 133-6.

8. Brown, D.A.: Lipid Rafts, Detergent-Resistant Membranes, and Raft Targeting Signals. Physiology 21, 2006, s. 430-439.

9. Chiorazzi, N., Rai, K.R., Ferrarini, M.: Chronic lymphocytic leukemia. N Engl J Med. 24, 2005, s. 804-15.

10. Cohen, A. W., Hnasko R., Schubert, W. et al.: Role of Caveolae and Caveolins in Health and Disease. Physiol. Rev. 84, 2004, s. 1341–1379.

11. Colomo, L., Lopez-Guillermo, A., Perales, M. et al.: Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood., 101, 2003, s. 78-84.

12. Cossman, J., Annunziata, C.M., Barash, S. et al.: Reed-Sternberg cell genome expression supports a B-cell lineage. Blood., 94, 1999, s.411-6.

13. Hancock, J.F.: Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol., 7, 2006, s. 456-62.

14. Hans, C.P., Weisenburger, D.D., Greiner, T.C. et al.: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 2004, s. 275-82.

15. Higuchi, M., Izumi, K.M., Kieff, E.: Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. U. S. A., 98, 2001, s. 4675-80.

16. Horejsí, V.: The roles of membrane microdomains (rafts) in T cell activation. Immunol. Rev., 191, 2003, s. 148-64.

17. Itoh, K., Sakakibara, M., Yamasaki, Y et al.: Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J. Immunol., 168, 2002, s. 541-4.

18. Jaffe, E.S., Harris, N.L., Stein, H. et al.: Pathology and genetics of tumors of haematopoetic and lymphoid tissues. WHO classification of tumors Lyon: IARC Press, 2001.

19. Janas, E., Priest, R., Wilde, J.I., White, J.H. et al.: Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis. Clin. Exp. Immunol., 139, 2005, s. 439-46.

20. Kuppers, R., Rajewsky. K., Zhao, M. et al.: Hodgkin’s disease: Hodgkin’s and Reed–Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. U.S.A., 91, 1994, s. 10962–6.

21. Lai, E.C.: Lipid rafts make for slippery platforms. J. Cell. Biol., 163, 2003, s. 365-70.

22. Lossos I.S., Alizadeh A.A., Eisen M.B. et al.: Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc. Natl. Acad. Sci. U. S. A., 97, 2000, s. 10209-10213.

23. Mancao, C., Hammerschmidt, W.: Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood, 110, 2007, s. 3715-21.

24. Marafioti, T., Hummel, M., Foss, H.D. et al.: Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood, 95, 2000, s. 1443-50.

25. Marguet, D., Lenne, P.F., Rigneault, H. et al.: Dynamics in the plasma membrane: how to combine fluidity and order. EMBO J., 25, 2006, s. 3446-57.

26. Michel, V., Bakovic, M.: Lipid rafts in health and disease. Biol. Cell., 99, 2007, s. 129–140.

27. Mone, A.P., Cheney, C., Banks, A.L. et al.: Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism. Leukemia, 20, 2006, s. 272-9.

28. Natkunam, Y., Lossos, I.S., Taidi, B. et al.: Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood, 105, 2005, s. 3979-86.

29. Ostrom, R.S., Insel, P.A.: Methods for the study of signaling molecules in membrane lipid rafts and caveolae. Methods. Mol. Biol., 332, 2006, s. 181-91.

30 Palade, G.E.: Fine structure of blood capillaries. J. Appl. Physiol., 24, 1953, s. 1424.

31. Pan, Z., Shen, Y., Ge, B. et al.: Studies of a germinal centre B-cell expressed gene, GCET2, suggest its role as a membrane associated adapter protein. Br. J. Haematol., 137, 2007, s.578-90.

32. Poppema, S.: Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology. Am. Soc. Hematol. Educ. Program., 2005, s.231-8.

33. Pralle, A., Keller, P., Florin, E.-L. et al.: Sphingolipid–cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell Biol. 148, 2000, s. 997–1007.

34. Rajendran L., Simons K.: Lipid rafts and membrane dynamics. J. Cell. Sci., 15, 2005, s. 1099-102.

35. Rosenwald, A., Alizadeh, A.A., Widhopf, G. et al.: Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med., 194, 2001, s. 1639-47.

36. Rosenwald, A., Wright, G., Chan, W.C. et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med., 346, 2002, s. 1937-47.

37. Schutz, G. J., Kada, G., Pastushenko, V. P. et al.: Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. EMBO J., 19, 2000, s.892–901.

38. Semac, I., Palomba, C., Kulangara, K. et al.: Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells. Cancer. Res., 63, 2003, s. 534-40.

39 Shaw, A.S.: Lipid rafts: now you see them, now you don’t. Nat. Immunol., 7, 2006, s. 1139-42.

40. Sun, Y., Orrenius, S., Pervaiz, S. et al.: Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance. Blood, 105, 2005, s. 4070-7.

41. Svec, A., Velenska, Z., Horejsi, V.: Expression pattern of adaptor protein PAG: Correlation between secondary lymphatic follicle and histogenetically related malignant lymphomas. Immunol. Lett., 100, 2005, s. 94-7.

42. Svec, A.: Expression of transmembrane adaptor protein PAG/Cbp in diffuse large B-cell lymphoma: immunohistochemical study of 73 cases. Pathol. Res. Pract. 203, 2007, s. 193-8.

43. Tauzin, S., Ding, H., Khatib, K. et al.: Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts. Blood, 111, 2008, s. 2310-20.

44. Tedoldi, S., Paterson, J., Cordell, J. et al.: Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. J. Pathol., 209, 2006, s. 454-63.

45. Tedoldi, S., Paterson, J.C., Hansmann, M.L. et al.: Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood, 107, 2006, s. 213-21.

46. van der Luit, A.H., Vink, R.S., Jeffrey, B. et al.: A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol. Cancer. Ther., 6, 2007, s. 2337–45.

47. Wu, L., Nakano, H., Wu, Z.: The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1. J. Biol. Chem., 281, 2006, s. 2162-9.

48. Yamada, E.: The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol., 1, 1995, s.445–458.

49. Zaas, D.W., Duncan, M., Rae Wright J. et al.: The role of lipid rafts in the pathogenesis of bacterial infections Biochim. Biophys. Acta., 1746, 2005, s. 305-13.

50. Zajchowski, L.D., Robbins, S.M.: Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur. J. Biochem., 269, 2002, s. 737-52.